BackLifecore Biomedical Overview

Lifecore Biomedical Receivables

Lifecore Biomedical's receivables is $11M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$10.67M

Peer average

Loading

Lifecore Biomedical Receivables History

Loading

Lifecore Biomedical vs. peers: Receivables Comparison

Loading

Lifecore Biomedical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lifecore Biomedical (LNDC) FAQ

The latest receivables for LNDC is $11M as of March 2026. Investors often review this figure alongside Lifecore Biomedical's historical trend and sector peers before judging valuation or financial health.

A receivables figure of $11M for LNDC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LNDC's receivables ($11M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Lifecore Biomedical's receivables against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.